Gestational diabetes, metformin, and risk of hypoglycemia

Am J Obstet Gynecol. 2021 Sep;225(3):352-353. doi: 10.1016/j.ajog.2021.05.029. Epub 2021 May 27.

Authors

María J Picón-César¹, María Molina-Vega¹, Stella González-Romero²

Affiliations

¹ Department of Endocrinology and Nutrition, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
² Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, Avenida de Carlos Haya 84, 29019 Málaga, Spain; CIBER Diabetes and Associated Metabolic Diseases, Madrid, Spain. Electronic address: marias.gonzalez.sspa@juntadeandalucia.es.

PMID: 34051168
DOI: 10.1016/j.ajog.2021.05.029

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetes, Gestational* / drug therapy
Diabetes, Gestational* / epidemiology
Female
Humans
Hypoglycemia* / chemically induced
Hypoglycemia* / epidemiology
Hypoglycemic Agents / adverse effects
Metformin* / adverse effects
Pregnancy

Substances

Hypoglycemic Agents
Metformin